Cargando…
Effect of pulsed intravenous methylprednisolone with alternative low-dose prednisone on high-risk IgA nephropathy: a 18-month prospective clinical trial
Full-dose prednisone (FP) regimen in the treatment of high-risk immunoglobulin A nephropathy (IgAN) patients, is still controversial. The pulsed intravenous methylprednisolone combined with alternative low-dose prednisone (MCALP) might have a more favorable safety profile, which has not been fully i...
Autores principales: | Li, Yan, Fu, Rongguo, Gao, Jie, Wang, Li, Duan, Zhaoyang, Tian, Lifang, Ge, Heng, Ma, Xiaotao, Zhang, Yuzhan, Li, Ke, Xu, Peihao, Tian, Xuefei, Chen, Zhao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8742122/ https://www.ncbi.nlm.nih.gov/pubmed/34996948 http://dx.doi.org/10.1038/s41598-021-03691-0 |
Ejemplares similares
-
Genetic variants of MCP-1 and CCR2 genes and IgA nephropathy risk
por: Gao, Jie, et al.
Publicado: (2016) -
A retrospective observational study of glucocorticoid-induced diabetes mellitus with IgA nephropathy treated with tonsillectomy plus methylprednisolone pulse therapy
por: Miyawaki, Yoshia, et al.
Publicado: (2017) -
The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019) -
Iron metabolism and chronic inflammation in IgA nephropathy
por: Tian, Zhang-yu, et al.
Publicado: (2023) -
IgA nephropathy with leucocytoclastic vasculitis
por: Wei, Lin-Yan, et al.
Publicado: (2018)